Notice of Intent to Sole Source to Sebia

Closed Special Notice Posted

Solicitation number
87783
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Norcross, Georgia 30093, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Centers for Disease Control and Prevention (CDC) has issued a Special Notice announcing its intent to award a sole source firm fixed price contract to Sebia Inc. for the purchase of one (1) dried blood spot (DBS) specimen testing equipment. This contract action is being pursued under the authority of FAR 6.302-1 and 10 U.S.C. 2304(c)(1).

The purpose of this Special Notice is to inform interested parties of the CDC's intent to sole source this requirement to Sebia Inc. and provide an opportunity for responsible sources to submit capability statements or proposals. The deadline for submitting any responses is 1:00 PM EST on September 3, 2024. While this is not a request for competitive quotations, the government will consider all submissions received by the deadline. The CDC retains sole discretion on whether to conduct a competitive procurement based on the information received. Eligibility is open to all responsible sources, though the CDC has determined Sebia Inc. to be the sole capable provider of the required DBS testing equipment.

Notice text

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price contract to Sebia Inc, 1704 Corporate Drive, Suite 400, Norcross, GA 30093 for the purchase of one (1) dried blood spot (DBS) specimen testing equipment.  This contract action is for services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 6.302-1 and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. All quotations/responses received by the deadline specified in this notice, in accordance with FAR 5.203, will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contracting specialist at ugo2@cdc.gov by 1:00 PM EST 3 September 2024.

Files

File Type Posted
SSJ_Redacted CO Signed.pdf PDF

Similar open opportunities

Opportunity Agency Set-aside Responses due
Notice of Intent to Sole Source a Thermo Orbitrap Fusion Lumos and Thermo RSLCnano UPLC Maintenance Agreement Georgia 30329, United States · NAICS 811210 CDC Office of Acquisition Services No set-aside
Notice of Intent to Sole Source – AB Sciex LLC Maryland 20892, United States · NAICS 339112 NIH Clinical Center No set-aside
1-Year OEM Service Contract - (2) Revvity Celigo S Imaging Instruments (VRC) Bethesda, Maryland 20892, United States · NAICS 811210 National Institute of Allergy and Infectious Diseases No set-aside
Notice of Award Maintenance for Government owned BacT/ALERT 3D Equipment. Medical Command No set-aside
Preventative Maintenance and FullCare Service Support for Cytiva Sepax C-PRO Cell Separation Systems Bethesda, Maryland 20892, United States · NAICS 811210 Office of Logisitics and Acquisition Operations No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors